American Academy of Child and Adolescent Psychiatry GUIDELINES Apps

ADHD

AACAP Clinical GUIDELINES App brought to you free of charge courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/100163

Contents of this Issue

Navigation

Page 11 of 11

*Generic formulations available. NOTES: ��� See product labeling for complete prescribing information. ��� If preexisting heart disease or family history of early-age sudden death, refer to pediatric cardiology for possible ECG and/or echocardiogram. ��� Use medications cautiously if history of tics. ��� Best dosage produces optimal efficacy with minimal side effects. ��� Start medication dosage trials on a Saturday so parent/caregiver can observe first-hand the effect of medication and dosage on the patient. ��� Most side effects can be managed through adjustments in dosage or schedule. ��� If appetite reduced or gastrointestinal side effects occur, give medication with or after meals. ��� Prescription refills afford opportunity to assess efficacy of therapy, adherence to regimen, and side effects. Content of this pocketcard has been adapted from: Key Points, ADHD Diagnostic Algorithm, ADHD Treatment Algorithm, Table 2, Table 3 American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894-921. Available at: http://www.aacap.org/galleries/PracticeParameters/ JAACAP_ADHD_2007.pdf Accessed: March 15, 2011. Table 1 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Press, Inc; 2000. Disclaimer This Guideline attempts to define principles of practice that should produce high-quality patient care. It focuses on the needs of primary care practice, but also is applicable to providers at all levels. This Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. The ultimate judgment concerning the propriety of any course of conduct must be made by the clinician after consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. 5740 Executive Drive��� Suite 218 Baltimore, MD 21228��� TEL: 410-869-3332��� ������ FAX: 410-744-2150��� For additional copies: orders@GuidelineCentral.com Copyright �� 2009 All rights reserved

Articles in this issue

Links on this page

Archives of this issue

view archives of American Academy of Child and Adolescent Psychiatry GUIDELINES Apps - ADHD